Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.

ABSTRACT: Thrombin activatable fibrinolysis inhibitor (TAFI), a proenzyme, is converted to a potent attenuator of the fibrinolytic system upon activation by thrombin, plasmin, or the thrombin/thrombomodulin complex. Since TAFI forms a molecular link between coagulation and fibrinolysis and plays a potential role in venous and arterial thrombotic diseases, much interest has been tied to the development of molecules that antagonize its function. This review aims at providing a general overview on the biochemical properties of TAFI, its (patho)physiologic function, and various strategies to stimulate the fibrinolytic system by interfering with (activated) TAFI functionality.

SUBMITTER: Sillen M 

PROVIDER: S-EPMC8036986 | biostudies-literature |

REPOSITORIES: biostudies-literature